Event: Texas MPN Workshop 2020

0:02:36

Highlights of the Texas MPN Workshop 2020

0:01:43

Texas MPN Workshop 2020

0:02:08

Looking forward to the Texas MPN Workshop 2020

0:01:26

What to look forward to from the Texas MPN Workshop 2020

0:01:52

First Annual Texas MPN Workshop (TMW) 2020

0:02:21

Key takeaways from the Texas MPN Workshop 2020

0:01:29

Highlights from this year's Texas MPN Workshop

0:02:34

Update on the management of patients with MPNs in transformation

0:01:53

Developing Therapeutic Strategies for Treating Accelerated and Blastic Phase MPN

0:03:55

Genomic updates in the field of MPNs

0:01:27

The use of interferons in the treatment of MPNs

0:03:15

What is the news about ropeginterferon?

0:02:45

An insight into clinical risk factors for progression in MPNs

0:01:20

To JAKi or not to JAKi - treating early MF

0:06:00

COVID-19 and MPN updates

0:01:23

The promise of CD123-targeted therapy in BPDCN

0:01:56

Ruxolitinib in 2020 and beyond

0:02:05

Insights into the main goals of the MPN Research Foundation

0:02:07

Avapritinib for indolent systemic mastocytosis

0:03:22

State-of-the-art developments in MPNs

0:03:23

Myelofibrosis: updates on JAK inhibitors

0:01:27

Ongoing trials and novel agents being explored in advanced and indolent systemic mastocytosis

0:02:06

Clinical updates on the use of ropeginterferon for polycythemia vera

0:04:10

The management of polycythemia vera with cytoreductive drug therapy